Detalles de la búsqueda
1.
Serum 14-3-3η as predictor of clinical remission and progression of structural damage in early rheumatoid arthritis following a treat-to-target strategy in a randomized controlled trial.
Scand J Rheumatol;
52(4): 342-352, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35833274
2.
Increased synovial galectin-3 induce inflammatory fibroblast activation and osteoclastogenesis in patients with rheumatoid arthritis.
Scand J Rheumatol;
52(1): 33-41, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35023445
3.
Baseline serum levels of IgA anti-cyclic citrullinated protein antibodies in early rheumatoid arthritis predict radiographic progression after 11 years of treatment: a secondary analysis of the CIMESTRA study.
Scand J Rheumatol;
52(5): 493-497, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36255383
4.
No difference in antidepressant prescription in rheumatoid arthritis and controls. Results from a population-based, matched inception cohort.
Scand J Rheumatol;
51(3): 173-179, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34182890
5.
Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial.
Scand J Rheumatol;
51(4): 268-278, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34474649
6.
Anti-cyclic citrullinated peptide antibodies, 28-joint Disease Activity Score, and magnetic resonance imaging bone oedema at baseline predict 11 years' functional and radiographic outcome in early rheumatoid arthritis.
Scand J Rheumatol;
48(1): 1-8, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30101636
7.
Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial.
Scand J Rheumatol;
48(1): 9-16, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29985080
8.
Impact of patient-reported flares on radiographic progression and functional impairment in patients with rheumatoid arthritis: a cohort study based on the AMBRA trial.
Scand J Rheumatol;
47(2): 87-94, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28841103
9.
Mortality and its predictors in patients with rheumatoid arthritis: a Danish population-based inception cohort study.
Scand J Rheumatol;
47(5): 371-377, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29741136
10.
Circulating serum interleukin-6, serum chitinase-3-like protein-1, and plasma vascular endothelial growth factor are not predictive for remission and radiographic progression in patients with early rheumatoid arthritis: post-hoc explorative and validation studies based on the CIMESTRA and OPERA trials.
Scand J Rheumatol;
47(4): 259-269, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29336711
11.
Galectin-3 is Persistently Increased in Early Rheumatoid Arthritis (RA) and Associates with Anti-CCP Seropositivity and MRI Bone Lesions, While Early Fibrosis Markers Correlate with Disease Activity.
Scand J Immunol;
86(6): 471-478, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28990250
12.
Hepcidin plasma levels are not associated with changes in haemoglobin in early rheumatoid arthritis patients.
Scand J Rheumatol;
46(6): 441-445, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28482738
13.
No diagnostic utility of antibody patterns against Klebsiella pneumoniae capsular serotypes in patients with axial spondyloarthritis vs. patients with non-specific low back pain: a cross-sectional study.
Scand J Rheumatol;
46(4): 296-302, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27600931
14.
Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA).
Scand J Rheumatol;
46(5): 335-345, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27775461
15.
Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis.
Pharmacogenomics J;
16(2): 141-6, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25939484
16.
Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA).
Ann Rheum Dis;
75(9): 1645-53, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26489704
17.
The discriminative value of inflammatory back pain in patients with persistent low back pain.
Scand J Rheumatol;
45(4): 321-8, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26982485
18.
Within-day variation and influence of physical exercise on circulating Galectin-3 in patients with rheumatoid arthritis and healthy individuals.
Scand J Immunol;
82(1): 70-5, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25857722
19.
Shared care or nurse consultations as an alternative to rheumatologist follow-up for rheumatoid arthritis (RA) outpatients with stable low disease-activity RA: cost-effectiveness based on a 2-year randomized trial.
Scand J Rheumatol;
44(1): 13-21, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25380077
20.
Interleukin-23 in early disease development in rheumatoid arthritis.
Scand J Rheumatol;
44(6): 438-42, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26087654